Citius Pharmaceuticals, Inc. (CTXR) stock
CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.54+0.00 (+0.51%)
Close on Nov 13, 2026Market cap $14.69MP/E –Yield –
Citius Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Citius Pharmaceuticals's enterprise value was $311.89M on Nov 11, 2026, against $331.74M a year earlier. Over the last 5 years it ranged from $20.27M to $331.74M, with a median of $134.78M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $311.89M | -2.5% |
| 2025 | Dec 31, 2025 | $319.76M | +974.4% |
| 2024 | Dec 31, 2024 | $29.76M | -68.4% |
| 2023 | Dec 29, 2023 | $94.30M | +26.8% |
| 2022 | Dec 30, 2022 | $74.40M | -52.1% |
| 2021 | Dec 31, 2021 | $155.34M | +261.3% |
| 2020 | Dec 31, 2020 | $42.99M | +98.9% |
| 2019 | Dec 31, 2019 | $21.62M | +182.1% |
| 2018 | Dec 31, 2018 | $7.66M | -73.1% |
| 2017 | Dec 29, 2017 | $28.51M | -11.4% |
| 2016 | Dec 30, 2016 | $32.18M | -3.4% |
| 2015 | Dec 31, 2015 | $33.30M | +77.9% |
| 2014 | Dec 31, 2014 | $18.72M | – |
See a number that looks wrong?